Nourish Snacks Pvt. Ltd. — Series A Investment Evaluation

Nourish is a premium functional snacking brand founded in 2021, built around clean-label, traditional Indian snacks reformulated for modern consumers — no refined sugar, clean-label ingredients, traditional Indian formats, science-backed formulations. The founding team pairs a brand builder (Unilever background) with a food scientist (IIT-B). The memo's headline verdict is CONDITIONAL BUY: Rs 40 Cr at Rs 135 Cr pre-money for a 22.9% stake, released across a three-tranche structure rather than as a single close.

The recommendation is conditional on five terms: entry at Rs 140 Cr rather than the founder's Rs 160 Cr ask (the memo's own final recommendation later tightens this further, to Rs 135 Cr); the milestone-gated Rs 25/10/5 Cr tranche structure; hiring a VP Marketing and a Regulatory Head within 60 days; a QComm GMV covenant that channel mix never exceed 45% of total GMV; and reporting subscription revenue as a standalone KPI from Day 1.

Four conditions would flip this recommendation to PASS: QComm Month-12 retention falling below 12% or LTV/CAC dropping below 3x (unit economics break); no own-label partner identified within 90 days (margin thesis weakens, FY27 breakeven slips); marketing spend exceeding 34% of revenue (the bear case becomes the base case and a bridge round is required); or a VP Marketing hire delayed beyond 60 days (growth efficiency deteriorates, scaling capability is called into question).

Nourish sells across four channels: D2C website, quick commerce, Amazon/Flipkart, and corporate gifting, targeting urban Indian health-conscious consumers aged 24-38. As of FY25E it runs 18 active SKUs across 25+ cities with 68 employees.

Growth highlights cited: +340% YoY growth in quick commerce, the fastest-scaling channel; 72% gross margin on D2C; and 41% Month-3 retention, with the subscription business described as scaling rapidly and protein snacks as the top-performing SKU category.

The memo builds TAM two ways and reconciles them. Bottoms-up: 97M urban households with income >Rs 50K/month, filtered to 63M health-aware households, spending an estimated Rs 1,895/household/year on health snacks, yields a TAM of Rs 11,939 Cr. Top-down: a Rs 5,500 Cr FY24 functional snacks market compounding at 32% CAGR reaches Rs 12,650 Cr by FY27, with D2C+QComm's addressable share of that category rising from 30% to 45%.

The category is bounded by a three-part definitional test — snack occasion, health claim present, and food format — used to include protein chikki and laddoo, clean-label makhana, trail mixes and seeds, protein bars and puffs, no-added-sugar snacks, and kids functional snacks, while excluding regular chips and namkeen, protein powders, energy drinks, traditional mithai, breakfast cereals, and supplements.

GMV grew from Rs 28L (FY22) to Rs 1,180L / Rs 11.8 Cr (FY25E), alongside a 62-percentage-point EBITDA margin improvement, from -75% in FY22 to -13% in FY25E. Gross margin has expanded steadily since FY22 to a 58% blend. Against Rs 4.5 Cr raised to date, the company has burned Rs 3 Cr — read by the memo as evidence of reasonable capital efficiency. Marketing spend sits at 39% of revenue, flagged as the key lever that must drop to 28-30% for the margin thesis to hold.

Nourish's FY24 GMV of Rs 11.8 Cr sits well behind The Whole Truth (~Rs 200 Cr), Happilo (~Rs 283 Cr), Oziva (~Rs 150 Cr), and Yoga Bar (~Rs 68 Cr, now ITC-owned). The competitive set bifurcates into two valuation tiers: FMCG/general-trade-heavy players (Happilo, RiteBite) trading at 2.4-6.5x revenue on acquisition, versus digital-first D2C players (The Whole Truth, Nourish) commanding growth-stage multiples of 13-17x. Which bucket Nourish exits in — a trade sale at FMCG multiples versus a Series C secondary at growth-stage multiples — is described as the most important strategic variable for exit planning, and depends on keeping D2C + subscription GMV share above 50% of total revenue.

Three threats are ranked over the next 24 months: ITC/Yoga Bar expansion into Indian snacks (High probability, Rs 8-12 Cr potential EV downside from margin erosion and pricing pressure); digital ad cost inflation, with CPMs already up 40-60% over three years and CAC risk of rising a further 20-50% (High); and QComm dependency / private-label compression from Blinkit or Zepto launching their own competing SKUs within 18-24 months, a potential Rs 300-500L GMV impact and 2-3% margin erosion by FY28 (Medium).

The memo's appendix maintains a 40-item assumptions and confidence registry, flagging every input by source and confidence level. Four are singled out as the ones most likely to change the recommendation.

The extended risk registry (Appendix F) ranks QComm private-label entry from Blinkit/Zepto and own-label sourcing failure as more underappreciated in the main deck than they should be — QComm private labeling could materialize within 18 months and directly threatens Nourish's fastest-growing channel, while own-label failure means the FY28 margin-bridge thesis collapses outright and the base case becomes structurally unachievable.

Success by Day 100 is defined as: margin ≥57%, retention improving, an own-label partner identified, subscription share increasing, and Tranche 2 on track. Kairon also commits three strategic introductions in this window — a CRM/retention agency, an own-label sourcing partner, and a VP Marketing candidate.

The founder's ask of Rs 160 Cr pre-money implies a 16.3x multiple on FY25 net revenue of Rs 9.79 Cr — above the memo's 8-15x Series A comparable range for Indian D2C peers. Four independent valuation methodologies are run to check this.

Multiple methodologies converge in the Rs 125-145 Cr range, and the memo recommends entry at Rs 135 Cr pre-money — Rs 40 Cr invested for a 22.9% stake at a Rs 175 Cr post-money valuation. The Rs 160 Cr ask is rejected specifically because it implies a 16.3x LTM multiple above the peer range despite unproven own-label sourcing, mid-range retention, and margin pressure already visible from the QComm mix shift.